Sfoglia per AUTORE
LARIBI K
Collezione AOU Città della Salute di Torino

  

Items : 3

2024
AOU Città della Salute di Torino
AOU Novara

Popov VM; Pangalis GA; Espinet B; Bosch F; Sportoletti P; Panagiotidis P; Gozzetti A; Oscier D; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Walewska R; Vukovic V; Vrachiolias G; Vitale C; Visentin A; Vassilakopoulos T; Tse E; Tomic K; Tadmor T; Stilgenbauer S; Soliman DSA; Smirnova S; Simkovic M; Shokralla T; Shen Y; Schiwitza A; et alii...

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.
2023
AOU Città della Salute di Torino
AOU Novara

Claus R; Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; et alii...

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. in Blood / Blood. 2016 Jun 9;127(23):2833-40. doi: 10.1182/blood-2016-01-694604. Epub 2016 Apr 18.
2016
AOU Città della Salute di Torino

Jakubowiak A; Offidani M; Pégourie B; De La Rubia J; Garderet L; Laribi K; Bosi A; Marasca R; Laubach J; Mohrbacher A; Carella AM; Singhal AK; Tsao LC; Lynch M; Bleickardt E; Jou YM; Robbins M; Palumbo A;